These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 39382685)

  • 1. Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis.
    Li J; Ma L; Sun H; Li M; Cao Y; Peng Y; Xu J
    Eur Arch Psychiatry Clin Neurosci; 2024 Oct; ():. PubMed ID: 39382685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression.
    Wang YT; Wang XL; Lei L; Guo ZY; Kan FF; Hu D; Gai C; Zhang Y
    Eur J Clin Pharmacol; 2024 Feb; 80(2):287-296. PubMed ID: 38117332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis.
    Chen CC; Zhou N; Hu N; Feng JG; Wang XB
    Neuropsychiatr Dis Treat; 2023; 19():587-599. PubMed ID: 36942150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
    Xiong J; Lipsitz O; Chen-Li D; Rosenblat JD; Rodrigues NB; Carvalho I; Lui LMW; Gill H; Narsi F; Mansur RB; Lee Y; McIntyre RS
    J Psychiatr Res; 2021 Feb; 134():57-68. PubMed ID: 33360864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
    Bahji A; Vazquez GH; Zarate CA
    J Affect Disord; 2021 Jan; 278():542-555. PubMed ID: 33022440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis.
    Bahji A; Zarate CA; Vazquez GH
    Expert Opin Drug Saf; 2022 Jun; 21(6):853-866. PubMed ID: 35231204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis.
    Rodolico A; Cutrufelli P; Di Francesco A; Aguglia A; Catania G; Concerto C; Cuomo A; Fagiolini A; Lanza G; Mineo L; Natale A; Rapisarda L; Petralia A; Signorelli MS; Aguglia E
    Front Psychiatry; 2024; 15():1325399. PubMed ID: 38362031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
    Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine.
    Singh B; Vande Voort JL; Pazdernik VK; Frye MA; Kung S
    J Affect Disord; 2024 Apr; 351():534-540. PubMed ID: 38302067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid anti-suicidal ideation effect of ketamine: A systematic review.
    Hochschild A; Grunebaum MF; Mann JJ
    Prev Med; 2021 Nov; 152(Pt 1):106524. PubMed ID: 34538369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials.
    Witt K; Potts J; Hubers A; Grunebaum MF; Murrough JW; Loo C; Cipriani A; Hawton K
    Aust N Z J Psychiatry; 2020 Jan; 54(1):29-45. PubMed ID: 31729893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.
    Zhou Y; Lan X; Wang C; Zhang F; Liu H; Fu L; Li W; Ye Y; Hu Z; Chao Z; Ning Y
    J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):507-518. PubMed ID: 37414272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review.
    Jollant F; Colle R; Nguyen TML; Corruble E; Gardier AM; Walter M; Abbar M; Wagner G
    Ther Adv Psychopharmacol; 2023; 13():20451253231151327. PubMed ID: 36776623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis.
    Terao I; Tsuge T; Endo K; Kodama W
    J Affect Disord; 2024 Feb; 346():49-56. PubMed ID: 37949235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis.
    Jawad MY; Di Vincenzo JD; Ceban F; Jaberi S; Lui LMW; Gillissie ES; Alnafeesi Y; Rosenblat JD; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):841-852. PubMed ID: 35387538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review.
    Siegel AN; Di Vincenzo JD; Brietzke E; Gill H; Rodrigues NB; Lui LMW; Teopiz KM; Ng J; Ho R; McIntyre RS; Rosenblat JD
    J Psychiatr Res; 2021 May; 137():426-436. PubMed ID: 33774537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis.
    Seshadri A; Prokop LJ; Singh B
    J Affect Disord; 2024 Jul; 356():379-384. PubMed ID: 38537759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy.
    Alario AA; Niciu MJ
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221128017. PubMed ID: 36276228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis.
    Nunez NA; Joseph B; Kumar R; Douka I; Miola A; Prokop LJ; Mickey BJ; Singh B
    Brain Sci; 2023 Dec; 13(12):. PubMed ID: 38137120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide.
    Whitaker T; Farrand KF; Thase ME
    Psychopharmacol Bull; 2024 Mar; 54(1):8-17. PubMed ID: 38449472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.